HONG KONG – As part of a unique financing and potential acquisition deal, Pvp Biologics, of San Diego, will work with Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, to fund and speed up the development of a new enzyme that can minimize the negative impact of gluten on celiac disease patients.

DOHA, Qatar – Tuberculosis, malaria, pandemic flu and an unknown disease are among the scariest infectious disease threats according to a group of experts gathered in Qatar for a global health summit. And, on a scale of one to 10, the state of readiness of the world to deal with such an outbreak was a resounding three.

DOHA, Qatar – Tuberculosis, malaria, pandemic flu and an unknown disease are among the scariest infectious disease threats according to a group of experts gathered in Qatar for a global health summit. And, on a scale of one to 10, the state of readiness of the world to deal with such an outbreak was a resounding three.

DOHA, Qatar – Advances in genomics have made mapping the genome of individuals both cheap and easy, but those same advances are leading to questions about the suitability of long-held practices of data-based research and a host of concerns of how to develop ethical standards.

DOHA, Qatar – Advances in genomics have made mapping the genome of individuals both cheap and easy, but those same advances are leading to questions about the suitability of long-held practices of data-based research and a host of concerns of how to develop ethical standards.

HONG KONG – Japan's embattled conglomerate Toshiba Corp. has plans to sell off between half and all of the shares of its medical equipment subsidiary as it restructures its operations in the wake of a multi-billion dollar loss last year.